Diclometide

This classification denotes an antipsychotic agent with the molecular formula C14H20Cl2N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 05186J17EP, chemically known as 3,5-dichloro-n-(2-(diethylamino)-ethyl)-o-anisamide. but generally known as diclometide, which bears US NIH Compound Identifier 208832. European Medicines Agency schedules Diclometide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07096MIG. The term DICLOMETIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 22, No. 10, 1968, List 8). DICLOMETIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diclometide under HS 29242995 and SITC 51479. As of Q4 2014, DICLOMETIDE remains the US FDA Preferred Term for this commodity. Diclometide bears US NLM identifiers UMLS ID C2699631 and NCI Concept Code C79127. SMILES: CLC1C(OC)C(C(=O)NCCN(CC)CC)CC(CL)C1.